Technical Analysis for CALT - Calliditas Therapeutics AB

Grade Last Price % Change Price Change
grade C 23.8 -4.03% -1.00
CALT closed down 4.03 percent on Friday, September 18, 2020, on 69 percent of normal volume.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent N/A Up Up
Historical CALT trend table...

Date Alert Name Type % Chg
Upper Bollinger Band Touch Strength 0.00%
MACD Bullish Centerline Cross Bullish -4.03%
Expansion Pivot Buy Setup Bullish Swing Setup -4.03%
Wide Range Bar Range Expansion -4.03%
Above Upper BB Strength -4.03%
Gapped Up Strength -4.03%
Upper Bollinger Band Touch Strength -4.03%
Crossed Above 20 DMA Bullish 1.54%
Crossed Above 50 DMA Bullish 1.54%
MACD Bullish Signal Line Cross Bullish 1.54%
Older End-of-Day Gignals for CALT ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
60 Minute Opening Range Breakout 2 days ago
Up 3% 2 days ago
Up 2% 2 days ago
Up 1% 2 days ago
Fell Below Previous Day's Low 2 days ago
View Earlier Intraday Alerts

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Calliditas Therapeutics AB is a specialty pharmaceutical company based in Stockholm, Sweden. It is focused on developing high quality pharmaceutical products for patients with a significant unmet medical need in niche indications, in which Calliditas can partially or completely participate in the commercialization efforts. Calliditas is focused on the development and commercialization of the product candidate Nefecon, a unique two step formulation optimized to combine a time lag effect with a concentrated release of the active substance budesonide, within a designated target area. This patented, locally acting formulation is intended for treatment of patients with the inflammatory renal disease IgA nephropathy (IgAN). Calliditas is running a global Phase 3 study within IgAN and aims to commercialize Nefecon in the United States.
Health Pharmaceutical Pharmaceutical Industry Pharmacy Medication Pharmaceutical Products Health Sciences Kidney Diseases Kidney Disease Pharmaceutics

Is CALT a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 28.38
52 Week Low 19.0
Average Volume 31,812
200-Day Moving Average 0.00
50-Day Moving Average 23.24
20-Day Moving Average 22.99
10-Day Moving Average 23.02
Average True Range 1.41
ADX 21.53
+DI 32.15
-DI 11.24
Chandelier Exit (Long, 3 ATRs ) 22.59
Chandelier Exit (Short, 3 ATRs ) 25.22
Upper Bollinger Band 24.14
Lower Bollinger Band 21.84
Percent B (%b) 0.85
BandWidth 10.03
MACD Line 0.16
MACD Signal Line 0.03
MACD Histogram 0.1388
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 27.28
Resistance 3 (R3) 27.60 26.75 26.70
Resistance 2 (R2) 26.75 25.87 26.60 26.51
Resistance 1 (R1) 25.28 25.32 24.86 24.96 26.31
Pivot Point 24.43 24.43 24.22 24.28 24.43
Support 1 (S1) 22.96 23.55 22.54 22.64 21.29
Support 2 (S2) 22.11 23.00 21.96 21.09
Support 3 (S3) 20.64 22.11 20.90
Support 4 (S4) 20.32